Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular GVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01393132
What this trial is testing

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren's SyndromeGraft vs. Host Disease
Michigan Cornea Consultants, PC 9
Post-approval studies (Phase 4)Study completedNCT05294666
What this trial is testing

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Who this might be right for
Graft Versus Host Disease in Eye
Peking University Third Hospital 89
Testing effectiveness (Phase 2)WithdrawnNCT04204122
What this trial is testing

Vigamox Treatment for Ocular Graft-Versus-Host Disease

Who this might be right for
Ocular Graft-versus-host Disease
Washington University School of Medicine
Not applicableStudy completedNCT01369914
What this trial is testing

The Natural History of Graft-Versus-Host Disease in the Eyes

Who this might be right for
Graft-Versus-Host Disease
National Eye Institute (NEI) 61
Not applicableLooking for participantsNCT06874283
What this trial is testing

Ocular Complications From Cancer Therapy - Patient Registry and Biobank

Who this might be right for
Graft Versus Host Disease in EyeOcular ComplicationsInflammatory Dry Eye Disease
University of Maryland, Baltimore 150
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Not applicableEnded earlyNCT00842413
What this trial is testing

Investigating the Role of the Premotor Cortex in Higher Cognitive Functions

Who this might be right for
Brain InjuryChronic
Assistance Publique - Hôpitaux de Paris 9
Not applicableStudy completedNCT07469865
What this trial is testing

Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)

Who this might be right for
Dry Eye Disease
University Hospital, Ghent 46
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Large-scale testing (Phase 3)UnknownNCT04769648
What this trial is testing

Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

Who this might be right for
Ocular Graft-versus-host Disease
Glia, LLC 44
Testing effectiveness (Phase 2)Ended earlyNCT01972438
What this trial is testing

A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients

Who this might be right for
Graft vs Host Disease
National Eye Institute (NEI) 18
Not applicableStudy completedNCT01234623
What this trial is testing

Cord Blood Serum in the Treatment of Ocular Surface Diseases

Who this might be right for
Graft vs Host DiseaseSjogren's Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Early research (Phase 1)Study completedNCT00102583
What this trial is testing

Cyclosporine Implant for Ocular Graft-Versus-Host Disease

Who this might be right for
Graft Vs Host Disease
National Eye Institute (NEI) 4
Testing effectiveness (Phase 2)Study completedNCT01616056
What this trial is testing

Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseOphthalmologic Complications
Fred Hutchinson Cancer Center 20
Not applicableUnknownNCT03064984
What this trial is testing

Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy

Who this might be right for
KeratopathySjogren's SyndromeGVHD - Graft-Versus-Host Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Testing effectiveness (Phase 2)Study completedNCT02040623
What this trial is testing

Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)

Who this might be right for
Chronic Graft-versus-host Disease
Rigel Pharmaceuticals 35
Very early researchStudy completedNCT04792580
What this trial is testing

The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

Who this might be right for
Graft-versus-host-diseaseOcular Graft-versus-host Disease
Richard W Yee, MD 30
Not applicableStudy completedNCT02411474
What this trial is testing

Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD

Who this might be right for
Chronic Graft-versus-host Disease
Yonsei University 21
Next Page